Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treat-to-Target Comparison of Two Basal Insulin Analogs (Insulin Lispro Protamine Suspension and Comparator) in Basal Therapy for Patients With Type 2 Diabetes Mellitus

NCT00494013 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.

NCT NCT00494013
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00494013 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treat-to-Target Comparison of Two Basal Insulin Analogs (Insulin Lispro Protamine Suspension and Comparator) in Basal Therapy for Patients With Type 2 Diabetes Mellitus
Lead sponsor
Eli Lilly and Company
Phase
Phase 3
Overall status
Completed
Start date
August 31, 2007
Completion date
September 30, 2008
Enrollment
442 (actual)
Sites
56

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus type 2